Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chubb
Medtronic
Cantor Fitzgerald
Fish and Richardson
Farmers Insurance
Colorcon
UBS
Federal Trade Commission

Generated: July 18, 2018

DrugPatentWatch Database Preview

Hydrocortisone cypionate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydrocortisone cypionate and what is the scope of hydrocortisone cypionate freedom to operate?

Hydrocortisone cypionate
is the generic ingredient in one branded drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are sixty-four drug master file entries for hydrocortisone cypionate.
Summary for hydrocortisone cypionate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 64
Bulk Api Vendors: 15
Patent Applications: 2,045
DailyMed Link:hydrocortisone cypionate at DailyMed
Synonyms for hydrocortisone cypionate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 3-cyclopentylpropanoate
11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl 3-cyclopentylpropanoate, (17.alpha.,21.beta.)
11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 21-cyclopentanepropionate
17-(3-cyclopentyl-1-propionyl)-11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione
17-Hydroxycorticosterone 21.beta.-cyclopentylpropionate
17-Hydroxycorticosterone 21beta-cyclopentylpropionate
2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 3-cyclopentylpropanoate
2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-DIHYDROXY-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL]-2-OXOETHYL 3-CYCLOPENTYLPROPANOATE
4XDY25L70B
508-99-6
AC1L5CF4
AK398666
AKOS027382851
BDBM50371265
C08176
C29H42O6
CHEBI:5783
CHEMBL1549
Cortef fluid
Cortef oral suspension
Cortisol 21-cyclopentanepropionate
cortisol cypionate
Cortisol, 21-cyclopentanepropionate
Cortisol, 21-cyclopentanepropionate (8CI)
CS-7123
D00976
DLVOSEUFIRPIRM-KAQKJVHQSA-N
DTXSID90872930
EINECS 208-091-0
HY-U00089
Hydrocortisone 21.beta.-cyclopentanepropionate
Hydrocortisone 21beta-cyclopentanepropionate
Hydrocortisone cipionate
Hydrocortisone cyclopentyl propionate
Hydrocortisone Cyclopentylpropionate
Hydrocortisone cypionate [USP]
Hydrocortisone cypionate(200 mg)
HYDROCORTISONECYPIONATE
LMST02030121
MLS002638159
NCI60_000174
NSC 10721
NSC-10721
NSC10721
PL009716
Pregn-4-ene-3, 21-(3-cyclopentyl-1-oxopropoxy)-11,17-dihydroxy-, (11.beta.)-
Pregn-4-ene-3,20-dione, 21-(3-cyclopentyl-1-oxopropoxy)-11,17-dihydroxy-, (11.beta.)-
Pregn-4-ene-3,20-dione, 21-(3-cyclopentyl-1-oxopropoxy)-11,17-dihydroxy-, (11beta)-
SCHEMBL41673
UNII-4XDY25L70B
ZINC4097470

US Patents and Regulatory Information for hydrocortisone cypionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CORTEF hydrocortisone cypionate SUSPENSION;ORAL 009900-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Dow
Healthtrust
Covington
Mallinckrodt
Daiichi Sankyo
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.